Jaber Samir, Rolle Amélie, Jung Boris, Chanques Gerald, Bertet Helena, Galeazzi David, Chauveton Claire, Molinari Nicolas, De Jong Audrey
Department of Anaesthesiology and Critical Care Medicine B (DAR B), Saint-Eloi Hospital, University Teaching Hospital of Montpellier, 80 avenue Augustin Fliche, 34295 Montpellier, France, Universite de Montpellier, Montpellier, Languedoc-Roussillon, France
PhyMed Exp, Université de Montpellier, INSERM U1046 Montpellier, France, Inserm U1046, Montpellier, Languedoc-Roussillon, France.
BMJ Open. 2020 Oct 7;10(10):e036718. doi: 10.1136/bmjopen-2019-036718.
Tracheal intubation is one of the most daily practiced procedures performed in intensive care unit (ICU). It is associated with severe life-threatening complications, which can lead to intubation-related cardiac arrest. Using a preshaped endotracheal tube plus stylet may have potential advantages over endotracheal tube without stylet. The stylet is a rigid but malleable introducer which fits inside the endotracheal tube and allows for manipulation of the tube shape; to facilitate passage of the tube through the laryngeal inlet. However, some complications from stylets have been reported including mucosal bleeding, perforation of the trachea or oesophagus and sore throat. The use of a stylet for first-attempt intubation has never been assessed in ICU and benefit remains to be established.
The endotracheal tube plus stylet to increase first-attempt success during orotracheal intubation compared with endotracheal tube alone in ICU patients (STYLETO) trial is an investigator-initiated, multicentre, stratified, parallel-group unblinded trial with an electronic system-based randomisation. Patients will be randomly assigned to undergo the initial intubation attempt with endotracheal tube alone (ie,without stylet, control group) or endotracheal tube + stylet (experimental group). The primary outcome is the proportion of patients with successful first-attempt orotracheal intubation. The single, prespecified, secondary outcome is the incidence of complications related to intubation, in the hour following intubation. Other outcomes analysed will include safety, exploratory procedural and clinical outcomes.
The study project has been approved by the appropriate ethics committee 'Comité-de-Protection-des-Personnes Nord-Ouest3-19.04.26.65808 Cat2 RECHMPL19_0216/STYLETO2019-A01180-57'". Informed consent is required. The results will be submitted for publication in a peer-reviewed journal and presented at one or more scientific conferences. If combined use of endotracheal tube plus stylet facilitates tracheal intubation of ICU patients compared with endotracheal tube alone, its use will become standard practice, thereby decreasing first-attempt intubation failure rates and, potentially, the frequency of intubation-related complications.
ClinicalTrials.gov Identifier: NCT04079387; Pre-results.
气管插管是重症监护病房(ICU)中最常进行的日常操作之一。它与严重的危及生命的并发症相关,可能导致与插管相关的心脏骤停。使用预塑形气管导管加管芯可能比不带管芯的气管导管具有潜在优势。管芯是一种刚性但可塑形的引导器,可装入气管导管内,用于操控导管形状,以利于导管通过喉入口。然而,已有报道称管芯会引发一些并发症,包括黏膜出血、气管或食管穿孔以及咽痛。在ICU中,尚未对首次插管尝试使用管芯进行评估,其益处仍有待确定。
气管导管加管芯与单纯气管导管相比用于增加ICU患者经口气管插管首次尝试成功率(STYLETO)试验是一项由研究者发起的、多中心、分层、平行组非盲试验,采用基于电子系统的随机分组。患者将被随机分配接受首次插管尝试,一组使用单纯气管导管(即不带管芯,对照组),另一组使用气管导管 + 管芯(试验组)。主要结局是首次经口气管插管成功的患者比例。唯一预先设定的次要结局是插管后1小时内与插管相关的并发症发生率。分析的其他结局将包括安全性、探索性操作和临床结局。
该研究项目已获得适当的伦理委员会“Comité-de-Protection-des-Personnes Nord-Ouest3-19.04.26.65808 Cat2 RECHMPL19_0216/STYLETO2019-A01180-57”的批准。需要获得知情同意。研究结果将提交至同行评审期刊发表,并在一个或多个科学会议上展示。如果与单纯气管导管相比,气管导管加管芯的联合使用有助于ICU患者的气管插管,其使用将成为标准操作,从而降低首次插管失败率,并有可能降低与插管相关并发症的发生率。
ClinicalTrials.gov标识符:NCT04079387;预结果。